{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:08:19Z","timestamp":1772136499109,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Research Council (MRC) Confidence in Concept award","award":["MC_PC_19042"],"award-info":[{"award-number":["MC_PC_19042"]}]},{"name":"MRC Discovery Medicines North Doctoral Training Program"},{"name":"National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre"},{"name":"National Institute for Health Research (NIHR) Senior Investigator award"},{"name":"NIHR Leeds Biomedical Research Centre and NIHR Leeds MedTech and In Vitro Diagnostic Evaluation Co-operative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Routine use of genetic data in healthcare is much-discussed, yet little is known about its performance in epidemiological models including traditional risk factors. Using severe COVID-19 as an exemplar, we explore the integration of polygenic risk scores (PRS) into disease models alongside sociodemographic and clinical variables. PRS were optimized for 23 clinical variables and related traits previously-associated with severe COVID-19 in up to 450,449 UK Biobank participants, and tested in 9,560 individuals diagnosed in the pre-vaccination era. Associations were further adjusted for (i) sociodemographic and (ii) clinical variables. Pathway analyses of PRS were performed to improve biological understanding of disease. In univariate analyses, 17 PRS were associated with increased risk of severe COVID-19 and, of these, four remained associated with COVID-19 outcomes following adjustment for sociodemographic\/clinical variables: hypertension PRS (OR\u2009=\u20091.1, 95%CI 1.03\u20131.18), atrial fibrillation PRS (OR\u2009=\u20091.12, 95%CI 1.03\u20131.22), peripheral vascular disease PRS (OR\u2009=\u20090.9, 95%CI 0.82\u20130.99), and Alzheimer\u2019s disease PRS (OR\u2009=\u20091.14, 95%CI 1.05\u20131.25). Pathway analyses revealed enrichment of genetic variants in pathways for cardiac muscle contraction (genes\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u20095;\n                    <jats:italic>beta[SE]<\/jats:italic>\n                    \u2009=\u20093.48[0.60]; adjusted\n                    <jats:italic>-P<\/jats:italic>\n                    \u2009=\u20091.86\u2009\u00d7\u200910\n                    <jats:sup>\u22125<\/jats:sup>\n                    ). These findings underscore the potential for integrating genetic data into epidemiological models and highlight the advantages of utilizing multiple trait PRS rather than a single PRS for a specific outcome of interest.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-86260-z","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T09:25:20Z","timestamp":1736933120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic proxies for clinical traits are associated with increased risk of severe COVID-19"],"prefix":"10.1038","volume":"15","author":[{"given":"N. J. M.","family":"Chaddock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. S. R.","family":"Crossfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pujades-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Iles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. W.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"1","key":"86260_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40246-021-00339-y","volume":"15","author":"JL Slunecka","year":"2021","unstructured":"Slunecka, J. L. et al. Implementation and implications for polygenic risk scores in healthcare. Hum. Genom. 15 (1), 46 (2021).","journal-title":"Hum. Genom."},{"issue":"5","key":"86260_CR2","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/ije\/dyac137","volume":"51","author":"SSR Crossfield","year":"2022","unstructured":"Crossfield, S. S. R., Chaddock, N. J. M., Iles, M. M., Pujades-Rodriguez, M. & Morgan, A. W. Interplay between demographic, clinical and polygenic risk factors for severe COVID-19. Int. J. Epidemiol. 51 (5), 1384\u20131395 (2022).","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"86260_CR3","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1038\/s41467-020-19966-5","volume":"11","author":"N Mars","year":"2020","unstructured":"Mars, N. et al. The role of polygenic risk and susceptibility genes in breast cancer over the course of life. Nat. Commun. 11 (1), 6383 (2020).","journal-title":"Nat. Commun."},{"key":"86260_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.amjcard.2021.02.032","volume":"148","author":"ME Weale","year":"2021","unstructured":"Weale, M. E. et al. Validation of an integrated risk tool, including polygenic risk score, for atherosclerotic cardiovascular disease in multiple ethnicities and ancestries. Am. J. Cardiol. 148, 157\u2013164 (2021).","journal-title":"Am. J. Cardiol."},{"key":"86260_CR5","unstructured":"England, H. E. NHS launches new polygenic scores trial for heart disease United Kingdom 2021.https:\/\/www.genomicseducation.hee.nhs.uk\/blog\/nhs-launches-new-polygenic-scores-trial-for-heart-disease\/"},{"issue":"9","key":"86260_CR6","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41596-020-0353-1","volume":"15","author":"SW Choi","year":"2020","unstructured":"Choi, S. W., Mak, T. S. & O\u2019Reilly, P. F. Tutorial: A guide to performing polygenic risk score analyses. Nat. Protoc. 15 (9), 2759\u20132772 (2020).","journal-title":"Nat. Protoc."},{"issue":"5","key":"86260_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1258\/jrsm.2010.100104","volume":"103","author":"FM Hajjaj","year":"2010","unstructured":"Hajjaj, F. M., Salek, M. S., Basra, M. K. & Finlay, A. Y. Non-clinical influences on clinical decision-making: A major challenge to evidence-based practice. J. R Soc. Med. 103 (5), 178\u2013187 (2010).","journal-title":"J. R Soc. Med."},{"issue":"1","key":"86260_CR8","doi-asserted-by":"publisher","first-page":"e000794","DOI":"10.1136\/bmjdrc-2019-000794","volume":"7","author":"CMY Lee","year":"2019","unstructured":"Lee, C. M. Y. et al. Comparing different definitions of prediabetes with subsequent risk of diabetes: An individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes. BMJ Open. Diabetes Res. Care 7 (1), e000794 (2019).","journal-title":"BMJ Open. Diabetes Res. Care"},{"issue":"7798","key":"86260_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (7798), 270\u2013273 (2020).","journal-title":"Nature"},{"key":"86260_CR10","doi-asserted-by":"publisher","first-page":"m1985","DOI":"10.1136\/bmj.m1985","volume":"369","author":"AB Docherty","year":"2020","unstructured":"Docherty, A. B. et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Prospective observational cohort study. BMJ 369, m1985 (2020).","journal-title":"BMJ"},{"issue":"7821","key":"86260_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson, E. J. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 584 (7821), 430\u2013436 (2020).","journal-title":"Nature"},{"issue":"10","key":"86260_CR12","doi-asserted-by":"publisher","first-page":"e1003374","DOI":"10.1371\/journal.pmed.1003374","volume":"17","author":"PM McKeigue","year":"2020","unstructured":"McKeigue, P. M. et al. Rapid Epidemiological Analysis of Comorbidities and treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study. PLoS Med. 17 (10), e1003374 (2020).","journal-title":"PLoS Med."},{"issue":"7889","key":"86260_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","volume":"600","author":"C-H-G Initiative","year":"2021","unstructured":"Initiative, C-H-G. Mapping the human genetic architecture of COVID-19. Nature 600 (7889), 472\u2013477 (2021).","journal-title":"Nature"},{"issue":"7848","key":"86260_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","volume":"591","author":"E Pairo-Castineira","year":"2021","unstructured":"Pairo-Castineira, E. et al. Genetic mechanisms of critical illness in COVID-19. Nature 591 (7848), 92\u201398 (2021).","journal-title":"Nature"},{"issue":"16","key":"86260_CR15","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","volume":"383","author":"D Ellinghaus","year":"2020","unstructured":"Ellinghaus, D. et al. Genomewide association study of severe Covid-19 with respiratory failure. N. Engl. J. Med. 383 (16), 1522\u20131534 (2020).","journal-title":"N. Engl. J. Med."},{"key":"86260_CR16","doi-asserted-by":"crossref","unstructured":"Hu, J., Li, C., Wang, S., Li, T. & Zhang, H. Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data. medRxiv (2020).","DOI":"10.1101\/2020.11.05.20226761"},{"issue":"6","key":"86260_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41588-021-00854-7","volume":"53","author":"JF Shelton","year":"2021","unstructured":"Shelton, J. F. et al. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat. Genet. 53 (6), 801\u2013808 (2021).","journal-title":"Nat. Genet."},{"issue":"4","key":"86260_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41588-021-01006-7","volume":"54","author":"JE Horowitz","year":"2022","unstructured":"Horowitz, J. E. et al. Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease. Nat. Genet. 54 (4), 382\u2013392 (2022).","journal-title":"Nat. Genet."},{"issue":"2","key":"86260_CR19","doi-asserted-by":"publisher","first-page":"e0247205","DOI":"10.1371\/journal.pone.0247205","volume":"16","author":"GS Dite","year":"2021","unstructured":"Dite, G. S., Murphy, N. M. & Allman, R. An integrated clinical and genetic model for predicting risk of severe COVID-19: A population-based case-control study. PLoS One 16 (2), e0247205 (2021).","journal-title":"PLoS One"},{"issue":"1","key":"86260_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41467-023-44250-7","volume":"15","author":"KL Brown","year":"2024","unstructured":"Brown, K. L., Ramlall, V., Zietz, M., Gisladottir, U. & Tatonetti, N. P. Estimating the heritability of SARS-CoV-2 susceptibility and COVID-19 severity. Nat. Commun. 15 (1), 367 (2024).","journal-title":"Nat. Commun."},{"issue":"3","key":"86260_CR21","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12 (3), e1001779 (2015).","journal-title":"PLoS Med."},{"key":"86260_CR22","unstructured":"Team, R. C. R: A language and environment for statistical computing Vienna, Austria: R Foundation for Statistical Computing. https:\/\/www.R-project.org\/ (2019)."},{"key":"86260_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"key":"86260_CR24","doi-asserted-by":"crossref","unstructured":"Choi, S. W. & O\u2019Reilly, P. F. PRSice-2: Polygenic risk score software for biobank-scale data. Gigascience 8 (7) (2019).","DOI":"10.1093\/gigascience\/giz082"},{"issue":"1","key":"86260_CR25","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8 (1), 1826 (2017).","journal-title":"Nat. Commun."},{"issue":"4","key":"86260_CR26","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: Generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11 (4), e1004219 (2015).","journal-title":"PLoS Comput. Biol."},{"issue":"7726","key":"86260_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562 (7726), 203\u2013209 (2018).","journal-title":"Nature"},{"issue":"D1","key":"86260_CR28","doi-asserted-by":"publisher","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","volume":"51","author":"E Sollis","year":"2023","unstructured":"Sollis, E. et al. The NHGRI-EBI GWAS catalog: Knowledgebase and deposition resource. Nucleic Acids Res. 51 (D1), D977\u2013D85 (2023).","journal-title":"Nucleic Acids Res."},{"key":"86260_CR29","unstructured":"23andMe. 23andMe 2022. https:\/\/www.23andme.com\/en-gb\/"},{"key":"86260_CR30","unstructured":"Health NIo. All of Us Research Program (2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86260-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86260-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86260-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T09:25:36Z","timestamp":1736933136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86260-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86260"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86260-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3181821\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"18 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared for the current manuscript. AWM has received research grant or educational funding or undertaken consultancy for the following pharmaceutical companies on behalf of the University of Leeds in the last 5 years: AstraZeneca, Kiniska Pharmaceuticals, Regeneron, Roche\/Chugai, Sanofi and Vifor. MPR is currently employed by Union Chimique Belge (UCB) Biopharma. None declared for MMI, NJMC, or SSRC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by UK Biobank (project 24559). UK Biobank has ethical approval from the National Research Ethics Committee (REC reference 11\/NW\/0382), and obtained informed electronic consent from all participants. There was no patient-public involvement in the study, which used non-identifiable data. All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"2083"}}